[Neuropsychological markers for the diagnosis of Alzheimer's disease] (Q51978708)

19 April 2018

review article

1 reference

title

[Neuropsychological markers for the diagnosis of Alzheimer's disease] (English)

1 reference

19 April 2018

1 reference

1 reference

Thomas-Anterion C

1 reference

19 April 2018

Laurent B

series ordinal

1 reference

19 April 2018

publication date

1 October 2006

1 reference

19 April 2018

published in

Revue neurologique

1 reference

19 April 2018

volume

162

1 reference

19 April 2018

issue

1 reference

19 April 2018

page(s)

913-920

1 reference

19 April 2018

The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Posterior cortical atrophy: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

[Validity of the five-word screening test for Alzheimer's disease in a population based study]

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

The neural basis of intrusions in free recall and cued recall: a PET study in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

'Prodromal Alzheimer's disease': a more useful concept than mild cognitive impairment?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

The FAB: a Frontal Assessment Battery at bedside.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

1 reference

7 January 2021

Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

[Frontal dysexecutive syndromes]

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Mild cognitive impairment, amnestic type: an epidemiologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Neuropsychological detection and characterization of preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Clinical and pathological characterization of progressive aphasia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Intrusions in Alzheimer's disease in immediate and delayed memory as a function of presentation modality.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Advances in the early detection of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Subjective memory complaints may announce dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

[Evaluation of memory for French public events: EVE-30 in 108 controls, 10 mild cognitively impaired and 10 Alzheimer's disease patients]

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

Is knowledge of famous people disproportionately impaired in patients with early and questionable Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975100-1

7 January 2021

10.1016/S0035-3787(06)75100-1

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018